Small secondary-market sale by a board member who is not an executive of TXG, negligible dilution signal. The $184K amount is immaterial relative to daily trading volume in TXG. Monitor Form 4 filings to confirm whether the sale executed, but this alone warrants no trading action.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 17 $32.13entry
- T+1 · 5mo ago +8.17%α +7.39% · $34.76
- T+5 · 5mo ago +7.69%α +8.73% · $34.60
- T+20 · 4mo ago +38.44%α +37.12% · $44.48
- T+60 · 2mo ago +113.48%α +110.33% · $68.59
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Board member Shehnaaz Suliman (ultragenyx CFO) filed intent to sell 5,723 shares of TXG Class A common stock worth approximately $184,395, executed through JP Morgan. Shares were acquired from RSU vesting over 2021-2024. The proposed sale is small relative to market cap and Suliman's likely holdings, and follows a pattern of insider selling at 10x Genomics.
Key Facts
- Filer: Shehnaaz Suliman, board member and CFO of ultragenyx (not TXG employee)
- Proposed sale: 5,723 shares of Class A common stock
- Estimated value: $184,395.06 (based on ~$32.23/sh)
- Broker: JP Morgan Securities LLC
- Shares acquired from RSU vesting between 2021 and 2024 (compensation-based)
- Filing date: June 16, 2026; proposed sale date also June 16, 2026
- Form 144 is intent to sell, actual sale not guaranteed
Financial Impact
approximately $184,000, representing less than 0.005% of TXG's $4.1B market cap
Risk Factors
- Insider selling from board members can indicate waning conviction, though here the scale is trivial
- TXG has seen recent insider selling ($1.4M over 30d), this filing adds to that pattern modestly
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001968582-26-000625 |
| Document: 0001968582-26-000625-index.html | 0001968582-26-000625 |
| Document: 0001968582-26-000625.txt | 0001968582-26-000625 |
Track record
28 reports on TXG
1 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $54.99 −0.74% settles Feb 12
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 5, 202611d ago 8-K Bullish 6/10 No price data
- Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $54.99 −7.24% settles Feb 4
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $65.29 Now $54.99 −15.78% settles Feb 1
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $54.99 −23.14% settles Jan 21
- Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $54.99 −28.84% settles Jan 5
- Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $54.99 −35.84% settles Dec 21
- Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $54.99 −27.28% settles Dec 17
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers